Chlamydia trachomatis
Scout Nabs $1M CARB-X Award for Point-of-Care Molecular STI Test
The company plans to use the funding to demonstrate proof of concept and feasibility for a rapid test to detect chlamydia and gonorrhea.
Binx Health, Cardinal Health Strike US Distribution Deal for Point-of-Care STD Test System
The Binx io molecular diagnostics system runs a test for Chlamydia trachomatis and Neisseria gonorrhoeae that previously received a CLIA waiver.
The firm said it has begun clinical trials of a 15-minute test to detect chlamydia and gonorrhea and expects to submit it for 510(k) clearance and CLIA waiver.
The firm has updated its low-cost Hub instrument and pivoted its testing menu toward multiplex point-of-care panels.
Qiagen Gets FDA Clearance for CT/NG Test on NeuMoDx MDx Systems
The test is the second to be cleared by the FDA on the systems and marks the firm's continuing efforts to expand the US NeuMoDx menu.
Oct 4, 2021
Sep 2, 2021
Mar 30, 2021
Binx Health Chlamydia and Gonorrhea Test CLIA Waived
Sep 15, 2020
Antelope Dx Completes €9M Series B Financing Round
Aug 15, 2018
Apr 16, 2018
FDA Clears Roche CT/NG Assay for 6800, 8800 Systems
Jan 23, 2017